This injection solution is available in concentrations ranging from 1 mg/ml to 20 mg/ml
Inconsistent quality in your diluent can lead to inconsistent research results
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
How to Use: Typical dosage is to inject 1 mL into the muscle or under the skin once per month Use a clean needle and syringe for each injection Follow your healthcare providers directions closely Warnings: Not for individuals with hypersensitivity to cobalt or vitamin B12 Use with caution in patients with Lebers disease or other optic nerve disorders In rare cases, high doses may lead to low potassium levels or allergic reactions
In laboratory studies, TB-500 has been evaluated for its interaction with actin-binding pathways, cytoskeletal organization, and cellular migration processes
Together, these peptides act on core hallmarks of aging: inflammation, oxidative stress, mitochondrial decline, and extracellular matrix degradation
.png)
